Pathological hypersecretory conditions
Heartburn; prevention and treatment (OTC use only)
Treatment of duodenal and gastric ulcers, GERD, hypersecretory states [Not FDA approved]
Renal Dose Adjustment
Hepatic Dose Adjustment
Cautions: Use cautiously in
Tagamet, Tagamet HB interacts with :
Pregnancy Category:B
Breastfeeding: This drug is compatible and considered safe with breastfeeding based upon data from AAP Policy Guidelines (available at http://aappolicy.aappublications.org/cgi/content/full/pediatrics;108/3/776). Limited information indicates that cimetidine is excreted in breastmilk in small amounts and would produce infant serum levels much less than those with direct dosages to the neonates. Due to the potential to cause hepatic enzyme inhibition, other drugs may be preferred. This information is based upon LactMed database (available at http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT last accessed 15 September 2010).
US Trade Name(s)
US Availability
cimetidine (generic)
Tagamet
Tagamet HB
Canadian Trade Name(s)
Canadian Availability
cimetidine (generic)
Novo-Cimetine
Nu-Cimet
UK Trade Name(s)
UK Availability
cimetidine (generic)
Tagamet
Australian Trade Name(s)
Australian Availability
cimetidine (generic)
Magicul
Tagamet
Pricing data from www.DrugStore.com in U.S.A.
Warning: This pricing information is subject to change at the sole discretion of DS Pharmacy. For the most current and up-to-date pricing information, please visit drugstore.com.